Compass Therapeutics
CMPX
CMPX
38 hedge funds and large institutions have $104M invested in Compass Therapeutics in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $106M → $104M (-$2.07M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.47M | |
| 2 | +$2.51M | |
| 3 | +$2M | |
| 4 |
BlackRock
New York
|
+$1.62M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.31M |
Top Sellers
| 1 | -$4.22M | |
| 2 | -$1.18M | |
| 3 | -$80K | |
| 4 |
MWM
Mascoma Wealth Management
Hanover,
New Hampshire
|
-$42K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$22.8K |